ATB Therapeutics logo

ATB Therapeutics

Antibody therapies developer for oncology and auto-immune disease.

1

Funding Rounds

$56.6m

Money raised

Overview

Antibody therapies developer for oncology and auto-immune disease.

Funding series

Funding Series Analysis

The company ATB Therapeutics has raised a total of $56.6m in funding over 1 rounds.

Key Insights:

  • ATB Therapeutics Series A Round: $56.6m
ATB Therapeutics logo
ATB Therapeutics Series A Round $56.6m

Industries

ATB Therapeutics is active in the following industries: